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ABSTRACT
Recently epidemiological studies suggest females lose neuroprotection from neurodegenerative diseases as
they go through menopause. It has been hypothesized that this neuroprotection is hormone‐dependent. The
current study characterized cell signaling molecules downstream of estrogen receptor beta that are known to
play a role in memory, PKC, ERK, and connexin‐43, in regions of the brain associated with memory decline in an
attempt to elucidate significant changes that occur post‐estrus. Total whole cell lysates were compared to
isolated mitochondrial protein because mitochondrial function is known to be altered during aging. As
hypothesized, protein concentrations differed depending on age, gender, and brain region. Additionally, many
of these changes occurred within mitochondria but not within whole cell lysates indicating that these are
epigenetic alterations. These findings accentuate the complexity of aging and provide insight into the gender‐
specific cellular processes that occur throughout this process.

INTRODUCTION
As people age, the prevalence of a variety of healthrelated symptoms commonly increase, such as: joint
pain, decreased muscle mass, fatigue, anxiety and
depression, and memory loss. The propensity for and
the disease severity for neurodegenerative diseases such
as Parkinson’s Disease, Alzheimer’s Disease, and stroke
also increase with age [1-5]. Mechanisms for this ageassociated phenomenon are currently unknown;
however, females experience higher levels of neuroprotection than males until they reach menopause [6-7].
Post-menopause, this protection from neurologic
disease diminishes resulting in lower protection than
their male counterparts. This loss of protection may be
one mechanism in which females have a higher
incidence and severity of stroke and neurodegenerative
diseases [7-8]. Because females experience a sudden
drop in estrogen levels during menopause [9], it has
been hypothesized that hormones may play a role in the
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neuroprotection noted early in female life. Furthermore,
we propose that gender is an important factor to
consider when evaluating the aging process.
Hormones such as estrogen and progesterone are tissuespecific signaling molecules that can regulate the
activity of the cerebral cortex, hippocampus, and
amygdala [10-11]. There are two isoforms of these
receptors, ER-alpha and ER-beta, both of which
regulate transcription [12]. Estrogen receptor beta is
expressed differentially throughout the brain and has
been implicated to have neuroprotective and tumor
suppressing functions in the aging brain [11-17].
Estrogen receptor-beta also signals within the mitochondria. This is relevant because mitochondrial
alterations have been correlated to age- and regionassociated changes in learning and memory [7];
however, the mechanisms for these changes for both
age and gender are unknown. Therefore, signaling
cascades that are both down-stream of estrogen receptor
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beta and which regulate respiration within the
mitochondria (PKC, cx43, and ERK) were quantified in
brain regions that correspond to these mental tasks in
order to begin to unravel this question.
Signaling pathways downstream of the estrogen
receptor-beta including protein kinase C (PKC), extracellular signal-related kinase (ERK), and connexin were
investigated in the current study. These proteins signal
within the mitochondria and have been implicated to
have altered activity levels throughout the aging process
[14-15, 18-25]. We hypothesize that changes in these
estrogen-responsive proteins will be gender and brain
region specific; providing insight into key signaling
alterations that occur during the aging process.
In this study, we characterized age-specific and genderspecific changes that occur in five brain regions
(cerebral cortex, hippocampus, amygdala, corpus
callosum, and cerebellum). These regions were selected
due to their known role in cognition, learning, and
memory throughout the aging process. Although all of
these regions are involved in cognition and memory,
which may decline with age; hormones have been
shown to play an important role in the regulation of the
cerebral cortex, hippocampus, and amygdala [11].
Because brain regions respond to aging differentially
[26], characterizing multiple regions provides a more
complete description of changes that occur during the
aging process, particularly as these regions are
associated with different neurodegenerative diseases.
This has been described in studies that have
characterized gross structural, region-specific changes
with age utilizing magnetic resonance imaging (MRI)
and computed tomography (CT) scans. For example, the
cerebral cortex, hippocampus, and cerebellum have
been shown to significantly decrease in volume with
age, while the amygdala undergoes very minimal
anatomical change throughout the aging process [2628]. Although large-scale morphological changes have
previously been shown to occur in several of the brain
regions investigated, continued exploration into what
alterations occur post-menopause may be vital to our
understanding of the role of estrogen depletion in the
loss of neuroprotection. The aim of the current study
was to characterize age-specific, gender-specific, and
brain region-specific alterations in proteins downstream
of the estrogen receptor. This study provides a
foundation for further research, as well as, insight into
the complexity of the aging process.

RESULTS
Because neurodegenerative changes associated with
Alzheimer’s disease have shown correlations with
gender-dependent severity, brain regions were selected
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dependent upon their association with learning and
memory. The cortex, hippocampus, cerebellum, and
cortical white matter (corpus callosum), are all areas
that have shown significant changes with age in human
MRI studies. These areas are also known to be highly
susceptible in Alzheimer’s disease, one example of a
disease in which the susceptibility and disease severity
significantly increase post-menopause in females [7].
Cerebral cortex – whole cell
In order to determine whether signaling downstream of
the estrogen receptor changed within the cortex over
time and between genders, protein was isolated from the
cerebral cortex of male and female rats at 4 timepoints
throughout their lifespan (4 weeks, 3 months, 9 months,
and 12 months of age; n = 3-4/gender/age). These
timepoints in the rat lifespan correspond to youth to
middle-age in humans (see Supplementary Table 1).
The cerebral cortex was not subdivided into specific
regions, and therefore contained the entire cortex for
each brain. Whole cell analysis for this region showed
that the protein concentration of p-ERK was
significantly different amongst the genders at nine
months of age (Figure 1A, 1B; p = 0.008). The male
rats had sig-nificantly higher concentrations of p-ERK
compared to the female counterparts (Figure 1A, 1B; p
= 0.008). Additionally, there was a trend for the
twelve-month males to also have higher concentrations
of p-ERK when compared to age-matched females
(Figure 1A, 1B; p = 0.091). Although this was not
statistically significant there was a trend which may
become significant if sample numbers were increased.
The concentrations of p-PKC, PKC, ERK, p-cx43, and
cx43 remained relatively constant regardless of gender
or age (Figure 1A, 1C-G). A graphical depiction of this
data can be seen in Figure 1.
Cerebral cortex – mitochondrial isolation
In order to determine whether signaling downstream of
the estrogen receptor changed within cortical
mitochondria over time and between genders, mitochondria were isolated from the cerebral cortex of male
and female rats at 4 timepoints throughout their lifespan
(4 weeks, 3 months, 9 months, and 12 months of age; n
= 3/gender/age). The concentration of p-cx43
significantly increased between four weeks of age and
three months of age (Figure 2A & 2B; p = 0.028).
There was also a significant difference between male
and female rats at twelve months of age (Figure 2A &
2C; p = 0.014), with the female rats having significantly
lower concentrations. Both genders experienced an
increase in mitochondrial p-cx43 concentration as they
aged from 4 weeks to 3 months of age (Figure 2A &
2D; p = 0.028); however, at the post-estrus age between
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9 months and 12 months, females experience a decrease
resulting in significantly lower p-cx43 concentration
compared to their male counterparts (Figure 2A & 2C; p
= 0.014).

Isolated mitochondria from the cortex also showed cx43
was found to significantly change with age (Figure 2A
& 2D). Both genders experienced a significant increase
in cx43 concentration between four weeks and nine

Figure 1. Signaling downstream of estrogen in the cerebral cortex across age and gender. Representative western blots
for each protein of interest and a representative Ponceau stain as a load control (A). Graphical depiction of the fold change for p‐
PKC (B), p‐PKC (C), ERK (D), ERK (E), p‐cx43 (F), cx43 (G), beta‐actin (H). Error bars = SEM. 4W = 4 weeks of age; 3M = 3 months of
age; 9M = 9 months of age; 12M = 12 months of age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05.
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months of age (Figure 2A & 2D; p = 0.021). This
increase may be related to normal growth and establishment of neural circuitry which continues into young
adulthood.

To start to identify the role of estrogen in mitochondrial
signaling, we analyzed the concentration of the estrogen
receptor beta, which showed a strong trend for gender
differences at four weeks of age. The four-week-old

Figure 2. Signaling downstream of estrogen in the mitochondria of the cerebral cortex across age and gender.
Representative western blots for each protein of interest and a representative Ponceau stain as a load control (A). Graphical
depiction of the fold change for for p‐cx43 comparing age (B), p‐cx43 comparing gender (C), cx43 (D), estrogen receptor beta (E),
PKC (F), ATP synthase (G). Error bars = SEM. 4W = 4 weeks of age; 3M = 3 months of age; 9M = 9 months of age; 12M = 12 months
of age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05.
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female rats had a strong trend showing elevated concentrations of estrogen receptor beta when compared to
the four-week-old male rats (Figure 2A & 2B; p = 0.056).

The concentration of PKC remained relatively constant
when comparing both age and gender in mitochondria
isolated from the cortex (Figure 2A & 2C). A graphical

Figure 3. Signaling downstream of estrogen in the hippocampus across age and gender. Representative western blots
for each protein of interest and a representative Ponceau stain as a load control (A). Graphical depiction of the fold change for p‐
PKC (B), PKC comparing age (C), PKC comparing gender (D), cx43 comparing age (E), cx43 comparing gender (F), p‐cx43 (G), p‐ERK
(H), ERK (I), beta‐actin (J). Error bars = SEM. 4W = 4 weeks of age; 3M = 3 months of age; 9M = 9 months of age; 12M = 12 months
of age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05. Pink * = p<0.05 for females only.
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depiction of this data and the alterations demonstrated
can be visualized in Figure 2.
Hippocampus – whole cell
In order to determine whether signaling downstream of
the estrogen receptor changed within the hippocampus
over time and between genders, whole cell lysate
proteins were isolated from the hippocampus of male
and female rats at 4 timepoints throughout their lifespan
(4 weeks, 3 months, 9 months, and 12 months of age; n
= 3-4/gender/age). Significant differences in p-PKC
were found when comparing males and females at
twelve months of age with males experiencing significantly lower concentrations than their female
counterparts (Figure 3A & 3B; p = 0.028). Although
not statistically significant, there was also a trend
implicating gender differences at four weeks of age
(Figure 3A & 3B; p = 0.090), and a decrease in p-PKC
in males between nine months and twelve months of
age (Figure 3A & 3B; p = 0.079). Larger sample sizes
may elucidate these findings.
Hippocampal whole cell analysis also demonstrated a
significant increas of PKC concentration within female
rats between four weeks of age and three months of age
(Figure 3A & 3C; p = 0.037). In addition to age-dependent alterations, there were also significant PKC concentration differences between genders at four weeks of
age (Figure 3A & 3D; p <0.001), nine months of age
(Figure 3A & 3D; p = 0.020), and twelve months of age
(Figure 3A & 3D; p = 0.015) with males experiencing
higher concentrations at all time points.
Both gender and age-dependent changes were noted for
cx43 (Figure 3A, 3E, & 3F). Female rats experienced a
significant increase in cx43 from four weeks of age to
twelve months of age (Figure 3A & 3E; p = 0.022), and
female rats also demonstrated significantly higher
concentrations of cx43 at twelve months of age
compared to their male counterparts (Figure 3A & 3F; p
= 0.002). There were no significant alterations noted
within p-cx43, p-ERK, or ERK concentrations across
gender or age (Figure 3A, 3G-I). A graphical depiction
of this data can be seen in Figure 3.

months of age (Figure 4A & 4B; male p = 0.031, female
p = 0.001). This increase was then followed by a
significant decrease of p-cx43 from nine months of age
to twelve months of age (Figure 4A & 4B; p = 0.009).
Additionally, female rats possessed a significantly
higher concentration of p-cx43 at nine months of age
compared to their male counterparts (Figure 4A & 4C; p
< 0.001).
Isolated mitochondria from the hippocampus also
showed altered expression of cx43. There was a
significant increase in cx43 from four weeks of age to
three months of age (Figure 4A & 4D; p = 0.012).
Similar to the alterations found with p-cx43, there was a
significant decrease in mitochondrial cx43 at twelve
months of age (Figure 4A & 4D; p = 0.017); however,
this was only seen in females. There was a significant
difference between male and female cx43 expression at
nine months of age, with female rats having
significantly more cx43 when compared to their male
counterparts (Figure 4A & 4E; p = 0.003).
Although not significantly different, the estrogen
receptor beta displayed a decreasing trend between nine
and twelve months of age (Figure 4A & 4B; p = 0.089).
The concentration of PKC remained relatively constant
regardless of age or gender (Figure 4A & 4G). A
graphical depiction of this data is presented in Figure 4.
Amygdala – whole cell
In order to determine whether signaling downstream of
the estrogen receptor changed within the amygdala over
time and between genders, whole cell lysate proteins
were isolated from the amygdala of male and female
rats at 3 timepoints throughout their lifespan (4 weeks, 3
months, and 9 months of age; n = 3/gender/age). No
animals at the 12-month timepoint were analyzed for
this brain region (Figure 5A-H). Although there were
not any significant differences in this study, it is
possible that differences exist given larger sample sizes
or at the later, aged timepoint that was not available for
this study in this region. A graphical depiction of these
findings can be seen in Figure 5.
Amygdala – mitochondrial isolation

Hippocampus - mitochondrial isolation
In order to determine whether signaling downstream of
the estrogen receptor changed within hippocampal
mitochondria over time and between genders, mitochondria were isolated from the hippocampus of male
and female rats at 4 timepoints throughout their lifespan
(4 weeks, 3 months, 9 months, and 12 months of age; n
= 3-4/gender/age). A significant increase in p-cx43 was
found for both genders from four weeks of age to three

www.aging‐us.com

2153

In order to determine whether signaling downstream of
the estrogen receptor changed within the mitochondria
from the amygdala over time and between genders,
mitochondria were isolated from the amygdala of male
and female rats at 3 timepoints throughout their lifespan
(4 weeks, 3 months, and 9 months of age; n = 3/gender/
age). Although whole cell analysis for the amygdala did
not show any significance, mitochondrial isolation for
the amygdala demonstrates age-dependent and gender-
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dependent alterations. There was a significant decrease
in the concentration of PKC between four weeks of age
and three months of age (Figure 6A & 6B; p = 0.036).

Additionally, 9-month female rats had significantly
higher mitochondrial PKC when compared to their male
counterparts (Figure 6A & 6C; p = 0.042). A trend for

Figure 4. Signaling downstream of estrogen in the mitochondria of the hippocampus across age and gender.
Representative western blots for each protein of interest and a representative Ponceau stain as a load control (A). Graphical depiction
of the fold change for p‐cx43 comparing age (B), p‐cx43 comparing gender (C), cx43 comparing age (D), cx43 comparing gender (E),
estrogen receptor beta (F), PKC (G), ATP synthase (H). Error bars = SEM. 4W = 4 weeks of age; 3M = 3 months of age; 9M = 9 months of
age; 12M = 12 months of age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05. Pink * = p<0.05 for females only.
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decreasing PKC in male rats from four weeks of age to
nine months of age was also noted (Figure 6A & 6C; p
= 0.077).

A trend for increased mitochondrial p-cx43 between
four weeks of age to nine months of age was also found
(Figure 6A & 6D; p = 0.067). Besides these significant

Figure 5. Signaling downstream of estrogen in the amygdala across age and gender. Representative western blots for
each protein of interest and a representative Ponceau stain as a load control (A). Graphical depiction of the fold change for p‐
PKC (B), PKC (C), p‐ERK (D), ERK (E), p‐cx43 (F), cx43 (G), beta‐actin (H). Error bars = SEM. 4W = 4 weeks of age; 3M = 3 months
of age; 9M = 9 months of age; 12M = 12 months of age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05.
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differences and observed trends, it was noted that the
concentration of mitochondrial cx43 and estrogen
receptor beta did not significantly change in the
amygdala and did not seem to be age-dependent or
gender-dependent (Figure 6A, 6B, 6F). All of this data
can be visualized in Figure 6.

Corpus callosum – whole cell
In order to determine whether signaling downstream of
the estrogen receptor changed within the corpus
callosum over time and between genders, whole cell
lysate proteins were isolated from the corpus callosum

Figure 6. Signaling downstream of estrogen in the mitochondria of the amygdala across age and gender.
Representative western blots for each protein of interest and a representative Ponceau stain as a load control (A). Graphical
depiction of the fold change for PKC comparing age (B), PKC comparing gender (C), p‐cx43 (D), cx43 (E), estrogen receptor beta
(F), ATP synthase (G). Error bars = SEM. 4W = 4 weeks of age; 3M = 3 months of age; 9M = 9 months of age; 12M = 12 months of
age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05.
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of male and female rats at 4 timepoints throughout
their lifespan (4 weeks, 3 months, 9 months, and 12
months of age; n = 3/gender/age). The corpus callosum
was yet another brain region that demonstrated significant age-dependent and gender-dependent changes
within the whole cell analysis. Female rats at twelve

months of age had significantly higher p-PKC than
their male counterparts (Figure 7A & 7B; p = 0.014).
There was also a significance decrease in the concentration of p-ERK between nine months of age and
twelve months of age (Figure 7A & 7C; males, p =
0.040).

Figure 7. Signaling downstream of estrogen in the corpus callosum across age and gender. Representative western blots
for each protein of interest and a representative Ponceau stain as a load control (A). Graphical depiction of the fold change for p‐PKC
(B), p‐ERK (C), p‐cx43 comparing gender (D), PKC (E), ERK (F), cx43 (G), beta‐actin (H). Error bars = SEM. 4W = 4 weeks of age; 3M = 3
months of age; 9M = 9 months of age; 12M = 12 months of age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05.
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When comparing genders, male rats experienced
notably higher concentrations of p-cx43 compared to
the female rats at four weeks of age (Figure 7A & 7D; p
= 0.047). Although statistical significance was not
demonstrated, the data indicated that gender differences
may exist within p-ERK at three months of age and nine
months of age given a larger sample size (Figure 7A &
7C; p =0.058 and p = 0.098, respectively). This may
also hold true for male rats between four weeks of age
and nine months of age, as the concentration of p-ERK
increased within this time period (Figure 7A & 7C; p =
0.057).
No significant differences were noted for PKC, ERK,
and cx43 when comparing gender and age (Figure 7A,
7E, 7F, & 7G). A graphical depiction of this data is
presented in Figure 7.
Corpus callosum - mitochondrial isolation
In order to determine whether signaling downstream of
the estrogen receptor changed within corpus callosum
mitochondria over time and between genders,
mitochondria were isolated from the corpus callosum of
male and female rats at 4 timepoints throughout their
lifespan (4 weeks, 3 months, 9 months, and 12 months
of age; n = 3/gender/age). Unlike the whole cell
analysis, the mitochondrial isolation analysis for the
corpus callosum only demonstrated age-dependent
changes. No significant gender differences were found.
PKC significantly decreased in both genders between
nine months of age and twelve months of age (Figure
8A & 8B; male, p = 0.005; female, p = 0.002). A
similar trend was noted in the concentration of p-cx43,
which also seemed to be decreased between nine
months of age and twelve months of age (Figure 8A &
8C; p = 0.059), although not statistically significant in
this study. The concentration of estrogen receptor beta
and cx43 did not significantly vary throughout the aging
process or across gender lines (Figure 8A, 8D, & 8E).
A graphical depiction of these findings can be
visualized in Figure 8.
Cerebellum – whole cell
In order to determine whether signaling downstream of
the estrogen receptor changed within the cerebellum
over time and between genders, whole cell lysate
proteins were isolated from the cerebellum of male and
female rats at 4 timepoints throughout their lifespan (4
weeks, 3 months, 9 months, and 12 months of age; n =
3/gender/age). Cerebellar whole cell analysis illuminated that the concentration of cx43 is age-dependent in
this region of the brain. It has been commonly known
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that cx43 decreases with age; therefore, the decrease in
cx43 in both genders between four weeks of age and
nine months of age, although not statistically significant, was not surprising. However, it was surprising
to find that within the cerebellum cx43 significantly
increased between nine and twelve months of age
(Figure 9A & 9B; p = 0.017).
While the concentration of p-PKC did not show
significant differences, it did reveal the possibility of
gender differences at nine months of age, where males
experienced increased levels of this protein (Figure 9A
& 9C; p = 0.058). There is also the possibility that
males have decreased p-PKC between nine months of
age and twelve months of age, although again the
threshold for statistical significance was not obtained
(Figure 9A & 9C; p = 0.054). No significant differences were noted in cerebellar PKC, p-ERK, ERK, and pcx43 regardless of age or gender (Figure 9A, 9C, 9D,
9E, & 9G). Data and controls are depicted graphically
in Figure 9.
Cerebellum – mitochondrial isolation
In order to determine whether signaling downstream of
the estrogen receptor changed within cerebellum
mitochondria over time and between genders, mitochondria were isolated from the cerebellum of male and
female rats at 4 timepoints throughout their lifespan (4
weeks, 3 months, 9 months, and 12 months of age; n =
3/gender/age). Contrary to the cerebellar whole cell
analysis, significant age-dependent and genderdependent alterations were found in the mitochondria of
the cerebellum. Females had significantly higher
mitochondrial estrogen receptor beta when compared to
age-matched males at three months of age (Figure 10A
& 10B; p = 0.041) and at nine months of age (Figure
10A & 10B; p = 0.018). Similarly, females had
significantly higher PKC when compared to agematched males at nine months of age (Figure 10A &
10C; p = 0.030) and at twelve months of age (Figure
10A & 10C; p = 0.015).
Beyond the gender-related changes, age-related
changes were seen within the concentration of p-cx43.
P-cx43 was significantly decreased between four
weeks and twelve months of age (Figure 10A & 10D;
p = 0.028), as well as between three and twelve
months of age (Figure 10A & 10D; p = 0.015). In the
cerebellum, the only protein investigated that did not
significantly vary throughout the aging process or
between genders was cx43 (Figure 10A & 10E). A
graphical depiction of these findings can be visualized
in Figure 10.
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Figure 8. Signaling downstream of estrogen in the mitochondria of the corpus callosum across age and gender.
Representative western blots for each protein of interest and a representative Ponceau stain as a load control (A). Graphical depiction of
the fold change for PKC (B), p‐cx43 (C), estrogen receptor beta (D), cx43 (E),ATP synthase (F). Error bars = SEM. 4W = 4 weeks of age; 3M
= 3 months of age; 9M = 9 months of age; 12M = 12 months of age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05.

Summary
A summary table indicating significant differences and
trends for each brain region and signaling protein data
can be found in Tables 1-4. Table 1 displays whole cell
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lysate protein concentration differences between males
and females for each brain region. Table 2 displays
significant differences in mitochondrial protein concentration differences between males and females for
each brain region. Table 3 summarizes significant
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changes with age in the whole cell lysate protein
concentrations for each brain region regardless of gender. Table 4 summarizes significant changes with age in
the mitochondrial proteins for each brain region regard-

less of gender. Statistically significant differences,
p<0.05, are indicated in yellow. Non-significant trends
with a p value between 0.05 and 0.10, are indicated in
light green.

Figure 9. Signaling downstream of estrogen in the cerebellum across age and gender. Representative western blots for
each protein of interest and a representative Ponceau stain as a load control (A). Graphical depiction of the fold change for cx43
with age (B), p‐PKC (C), PKC (D), p‐ERK (E), ERK (F), p‐cx43 (G), beta‐actin (H). Error bars = SEM. 4W = 4 weeks of age; 3M = 3 months
of age; 9M = 9 months of age; 12M = 12 months of age. Pink = female; blue = male. ANOVA with Tukey posthoc, * = P<0.05.
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Figure 10. Signaling downstream of estrogen in the mitochondria of the cerebellum across age and gender.
Representative western blots for each protein of interest and a representative Ponceau stain as a load control (A). Graphical
depiction of the fold change for estrogen receptor beta (B), PKC (C), p‐cx43 (D), cx43 (E), ATP synthase (F). Error bars = SEM.
4W = 4 weeks of age; 3M = 3 months of age; 9M = 9 months of age; 12M = 12 months of age. Pink = female; blue = male.
ANOVA with Tukey posthoc, * = P<0.05.
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Table 1. Summary of significant whole cell protein changes with gender.
Cortex

Hippocampus
4wk M>F
9mo M>F

PKC

Corpus Callosum

Cerebellum

12mo F>M

9mo M>F

12mo M>F
p-PKC
ERK
p-ERK

4wk M>F
12mo F>M
9mo M>F
12mo M>F

cx43
p-cx43

3mo M>F
9mo M>F
12mo F>M
4wk M>F

n = 3‐4/age/gender/group. Yellow = p<0.05. Green = trend but non‐significant

Table 2. Summary of significant mitochondrial protein changes with gender.
Cortex
ER-beta

Hippocampus

Amygdala

Corpus Callosum

4wk F>M

PKC

9mo F>M

cx43
p-cx43

12mo M>F

Cerebellum
3mo F>M
9mo F>M
9mo F>M
12mo F>M

9mo F>M
9mo F>M

n = 3‐4/age/gender/group. Yellow = p<0.05. Green = trend but non‐significant

Table 3. Summary of significant whole cell protein changes with Age regardless of gender.
Cortex
PKC
p-PKC
ERK
p-ERK
cx43

Hippocampus
Inc 4wk-3mo
Dec 9mo-12mo

Corpus Callosum

Cerebellum
Dec 9mo-12mo

Inc 4wk-9mo
Dec 9mo-12mo
Inc 4wk-12mo

Dec 4wk-9mo
Inc 9mo-12mo

p-cx43
n = 3‐4/age/gender/group. Yellow = p<0.05. Green = trend but non‐significant

Table 4. Summary of significant whole cell protein changes with Age regardless of gender.
Cortex

Hippocampus
Amygala
Corpus Callosum
Cerebellum
Dec 9mo-12mo
Inc 4wk-3mo
Inc 4wk-9mo
Dec 9mo-12mo F
p-cx43Figure 10. Signaling downstream
Inc 4wk-3mo
4wk-12mo
of estrogen in the mitochondria of the cerebellum across ageDec
and
gender.
Inc 4wk-3mo
Inc 4wk-9mo
Dec 9mo-12mo
Representative western blots for
each
protein of interest and a representative Ponceau stain as a load control
(A).3mo-12mo
Graphical
Dec
9mo-12mo
Dec
p‐cx43 (D), cx43 (E), ATP synthase (F). Error bars = SEM. 4W
PKC depiction of the fold change for estrogen receptor beta (B), PKC
Dec(C),
4wk-3mo
= 12 months ofDec
age.9mo-12mo
Pink = female; blue = male. ANOVA
= 4 weeks of age; 3M = 3 months of age; 9M = 9 months of age;
Dec 12M
4wk-9mo
ER-beta
cx43

with Tukey posthoc, * = P<0.05.

n = 3‐4/age/gender/group. Yellow = p<0.05. Green = trend but non‐significant
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DISCUSSION
Females have a longer life expectancy than males in
mammals, including humans [29-30]. Because this
prolonged lifespan is not exclusive to humans, socioeconomic factors cannot be entirely to blame. This hints
that a gender-specific biological differences, such as
hormone regulation, may contribute to this phenomenon. Similarly, epidemiological studies have shown that
there are gender- and age-dependent factors that
correspond to the incidence and/or severity of various
age-related neurodegenerative diseases. For example,
males have an earlier onset and increased prevalence for
Parkinson’s disease (PD) than age-matched females
[31]. Likewise, females have been shown to have an
increase in neuroprotection from stroke severity premenopause [7-9]. These gender-related studies have led
to the hypothesis that the positive effects of estrogen on
cellular processes may be one mechanism by which
females have early life protection from neurodegenerative symptoms, and ultimately a longer lifespan. The mechanism(s) by which estrogen is neuroprotective is unknown; however, it has been well
documented that estrogen can modify immune competence, reactive oxygen species (ROS) production, and
telomere maintenance [32-33].
The loss of estrogen midlife, post-estrus, may argue that
this neuroprotection declines at menopause. In fact,
evidence does show that post-menopausal women have
a higher incidence of Alzheimer’s Disease (AD) than
men, as well as a faster cognition decline after disease
onset [34-35]. Furthermore, the severity of stroke
increases dramatically post menopause [7-9]. In addition, Bake S & Sohrabji F. showed that the increased
Blood Brain Barrier permeability in aged, post-estrus
rats could not be rescued with estrogen replacement
therapy as it could in young females post ovarectomy
[36] – suggesting that there are alterations post-estrus
that do not allow the cells to respond to estrogen
replacement therapy as in younger animals. These data
suggest that loss of estrogen can indeed decrease neuroprotection in females. Since females tend to live longer,
this may seem counter-intuitive. However, longer
lifespan has also been correlated to later stage
menopause [37], which may suggest that the lifetime
cumulative exposure to estrogen exerts a long-lasting
effect. Altogether, we suggest that gender and hormone
regulation are biological variables that may be important when considering both normal aging and ageassociated neurodegenerative diseases.
The mechanism(s) for hormone-associated neuroprotection and the dramatic decline in females at
menopause is yet unknown. The current study examined
cell signaling molecules downstream of the estrogen
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receptor-beta over the lifespan of both male and female
rats to attempt to elucidate significant changes that
occur during the post-estrus change.
We propose that gender-dependent hormone
fluctuations with age may be one factor that determines
why neuroprotection differs between males and
females, which can be more pronounced during the nonestrus, or menopausal stage of female life. The decline
in estradiol noted in the aged (9-month and 12-month
female rats) corresponded with significant changes in
PKC, p-PKC, p-ERK and cx43 protein concentrations
throughout the brain, but most notably within the
hippocampus of female rats during those timeframes.
Decreased expression of PKC isoforms with age in the
hippocampus and frontal cortex have been linked to
significant declines in spatial memory [6]. Furthermore,
in a 2016 review Orellana JA et al. expound upon the
necessity of cx43 for memory consolidation throughout
the brain [38]. However, these previous studies did not
differentiate between gender. Our findings show significant gender-dependent alterations within both PKC and
cx43 within the hippocampus and cortex. Moreover,
given the historical links of PKC and cx43 to memory
during neurodegeneration and aging, the correlations
provided from this study indicate the possibility of
linking these pathway changes to the memory
alterations noted and further explain the genderdependent changes at this age in females. Further experiments to define whether a decline in memory is
hormone-dependent in females at this time are planned.
Data from this study also correlates the decrease in
estradiol levels with significant differences between
male and female cx43 and p-cx43 in hippocampal
mitochondria, and mitochondrial PKC concentrations
within the cerebellum. Mitochondrial PKC and cx43
have been previously shown to regulate oxidative
phosphorylation in the mitochondria [39-41]; therefore,
an age-dependent decline in mitochondrial cx43 and pcx43 would be indicative of non-optimal mitochondrial
respiration often found in neurodegenerative diseases.
This is consistent with previous reports that showed
attenuation of oxidative stress and mitochondrial dysfunction were sufficient to improve the memory in a
mouse model for Alzheimer’s Disease [42]; and
suggests that the loss of hormones at this critical time of
life may contribute to the increased cognitive and
learning and memory deficit severity noted in this
population due to mitochondrial signaling alterations.
Mitochondrial cx43 and p-cx43 significantly increased
as the rats aged between the adolescent 4-week age and
more adult 3-month to 12-month ages in the cortex and
hippocampus regardless of gender. Significant
decreases in these protein concentrations were not
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found until the 9 and 12-month post-estrus age in
female rats, and this decrease was gender-specific. It is
interesting to note here that these alterations in cx43 and
p-cx43, which both correspond to the ages of neuroprotection and memory development early in life and
decline with age, are only found in the mitochondrial
fractions and were not found to be significantly different in the whole cell lysates. Similarly, PKC from
the mitochondrial isolates but not whole cell lysates
also significantly decreased in the corpus callosum at
the 9 and 12-month, aged timepoint regardless of
gender. These discoveries are important because while
PKC and cx43 have been associated with age and
memory loss, the distinction between the mitochondrial function and that of signaling elsewhere in
the cell is novel.
PKC and cx43 are both known down-stream targets of
estrogen and are known to regulate mitochondrial
respiration. These proteins experienced expression
changes throughout the aging process, some of which
were gender-dependent. These expression changes
varied based on the localization of the protein, within
whole cell lysate or isolated mitochondria, suggesting
that the altered protein concentration is likely secondary
to epigenetic changes rather than genetic changes.
Finding statistical significance with such a small sample
size using an in vivo rat model elucidates just how
dramatic some of these alterations are.
While the current study does not focus upon the Blood
Brain Barrier, disruption of this barrier has been
correlated to normal aging as well as many neurodegenerative diseases. Mitochondrial dysfunction has
also been highly correlated to neurodegenerative disease

and Blood Brain Barrier disruption. Therefore, we
propose a potential mechanism by which loss of
estrogen post estrus can result in decreased mitochondrial function and increased permeability of the
Blood Brain Barrier (Figure 11). In this model, loss of
estrogen post menopause results in a reduction of pPKC
and p-cx43 leading to decreased mitochondrial function,
increased ROS production and ultimately an increase in
Blood Brain Barrier permeability.
Not only do each of the brain regions investigated
demonstrate unique age-dependent alterations, but they
also all demonstrate gender-dependent alterations.
Although numerous cellular signaling pathways may be
involved in these alterations, signaling downstream of
the estrogen receptor-beta seems to have a pronounced
role. Several of the proteins involved within this signaling cascade experienced expression changes throughout
the aging process. Of the proteins examined, only ERK
remained relatively constant throughout all age groups,
genders, and brain regions.
Data from this study also correlates the decrease in
estradiol levels with significant differences between
male and female cx43 and p-cx43 in hippocampal
mitochondria, and mitochondrial PKC concentrations
within the cerebellum. This fits with previous reports
where attenuation of oxidative stress and mitochondrial dysfunction were sufficient to improve the
memory in a mouse model for Alzheimer’s Disease
[42]; and suggests that the loss of hormone at this
critical time of life may contribute to the increased
cognitive and learning and memory deficit severity
noted in this population due to mitochondrial signaling
alterations.

Figure 11. Schematic representation of a potential mechanism by which loss of estrogen post estrus
can result in decreased mitochondrial function and increased permeability of the Blood Brain Barrier.
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Aging is an extremely intricate, complex process that
involves changes in a variety of genes, protein signaling
pathways, and epigenetic factors. It is noted that we
only examined a small subset of estrogen-responsive
proteins; however, each brain region studied did
demonstrated unique age-dependent and gender-dependent signaling protein concentration alterations. These
significant protein concentration changes will allow for
focused region-specific future studies that will help
unravel mechanisms behind neuroprotection and
memory changes with age and gender.

MATERIALS AND METHODS
Animals and tissue harvesting
Forty-seven Sprague Dawley rats were obtained
(Charles River Laboratories) and were split into four
age groups (4 weeks, 3 months, 9 months, and 12
months of age), for both males and females. Each of
these groupings were repeated so that tissue could be
isolated for both total cellular analysis and for mitochondrial fractionalization studied (n=3-4 per group).
Blood was collected from each animal after euthanasia
but before cardio-perfusion via a cardiac draw. Elisa
assays for estradiol levels were performed to correlate
the age-associated decline in estradiol levels and to
assess post-estrus status in 9-12 month old females (data
not shown). Each rat was euthanized using an intraperitoneal injection of phenobarbital. A foot pinch or
tail pinch test was performed to ensure no withdrawal
reflex was elicited, and to confirm that the rat had been
appropriately anesthetized. Cardio-perfusion was then
performed using ice cold 1× phosphate buffered saline
(PBS). Brain regions were dissected, flash frozen in
liquid nitrogen, and stored at -80°C.
Tissue homogenization - whole cell
Tissue samples were homogenized in lysis buffer
containing 1% phosphatase inhibitor cocktail 2, 1%
phosphatase inhibitor cocktail 3, 1% phenylmethylsulfonyl fluoride, and 4% cOmplete EDTA-free
protease inhibitor cocktail. They were then centrifuged
for ten minutes (12,000 rpm at 4°C), and the pellet and
supernatant were frozen and stored at -80°C.
Mitochondrial isolation
This mitochondrial isolation procedure is a modified
version of the mitochondrial isolation protocol provided
by Cold Springs Harbor Laboratory Press (Cold Spring
Harb Protoc; doi:10.1101/pdb.prot080002). Samples
were incubated in RBS hypobuffer containing 1%
phosphatase inhibitor cocktail 2, 1% phosphatase
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inhibitor cocktail 3, 1% phenylmethylsulfonyl fluoride,
and 4% cOmplete EDTA-free protease inhibitor
cocktail for five minutes before being homogenized for
ten minutes using a micro tube homogenizer. Immediately after homogenization, 2.5×MS homogenization
buffer was added to each sample. The samples were
mixed by inversion five times, transferred to a 1.5 mL
microcentrifuge tube, centrifuged for five minutes
(1,300 g at 4°C), and the supernatant was transferred to
a new 1.5 mL microcentrifuge tube. This process was
performed three times, transferring the supernatant to a
new 1.5 mL microcentrifuge tube each time. After the
third round of centrifugation supernatant was then
centrifuged for fifteen minutes (12,000 g at 4°C). The
remaining supernatant after this final centrifugation was
transferred to a new 1.5 mL microcentrifuge tube. The
pellet from the final centrifugation was resuspended
with 100 µL of 1×MS homogenization buffer (1%
phosphatase inhibitor cocktail 2, 1% phosphatase
inhibitor cocktail 3, 1% phenylmethylsulfonyl fluoride,
and 4% cOmplete EDTA-free protease inhibitor
cocktail). The three pellets, the final supernatant, and
the resuspended sample were all frozen and stored at 80°C.
Western blotting
A BCA protein assay was performed to determine the
total protein concentration of each sample using a
Pierce BCA Assay Protein Kit. Western blots were
performed at described previously [43]. The primary
antibodies that were used throughout this study were:
1:1,000 Anti-Phospho-PKC alpha (Ser657) goat
polyclonal (Santa Cruz Biotechnologies, Product
number: sc-12356), 1:1,000 Anti-PKC alpha rabbit
polyclonal (Cell Signaling Technology, Product
number: 2056S), 1:1,000 Anti-Phospho-p44/42 ERK
(Thr202/Tyr204) XP rabbit monoclonal (Cell Signaling
Technology, Product number: 4370S), 1:1,000 Antip44/42 ERK (L34F12) mouse monoclonal (Cell
Signaling Technology: Product number: 4696S), 1:500
Anti-Estrogen receptor beta rabbit polyclonal (Invitrogen, Product number: PA1-310B), 1:1,000 AntiPhospho-Connexin 43 (Ser368)(D6W8P) rabbit
monoclonal (Cell Signaling Technology, Product
number: 52559S), 1:8,000 Anti-Connexin 43 (GJA1)
rabbit polyclonal (Abcam, Product number: ab11370),
1:1,000 Anti-ATP5B (R-20) goal polyclonal (Santa
Cruz Biotechnology, Product number: SC-16689), and
1:5,000 Anti-Beta-actin (13E5) rabbit monoclonal (Cell
Signaling Technology, Product number: 4970S). The
secondary antibodies that were used throughout this
study were: 1:4,000 Donkey Anti-Goat Horse Radish
Peroxidase (HRP) conjugated IgG (Santa Cruz
Biotechnologies, Product number: sc-2033), 1:5,000
Anti-Mouse HRP-conjugated IgG (Cell Signaling
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Technology, Product number: 7076S), and 1:5,000 or
1:10,000 Anti-Rabbit HRP-conjugated IgG (Cell
Signaling Technology, Product number: 7074S).
Each membrane utilized two processes to verify even
protein loading to each well. All blots were stained
with Ponceau as a total protein loading control. For
mitochondrial isolation, membranes were also probed
with 1:1,000 Anti-ATP5B antibody. For whole cell
lysates, the load controls utilized beta-actin (1:5000).
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Analysis
X-ray film was scanned using a HP Scanjet 3970,
grayscale coloring, and a resolution of 1200 dpi. Bands
were quantified using ImageJ Software, and band
intensities were normalized as a ratio to corresponding
load control values. A two-way ANOVA with Tukey
Post-hoc testing was performed to determine statistical
significance using SigmaPlot v14.0. Line graphs were
created using GraphPad Prism 7 and demonstrate the
mean ± standard error of mean for each group.
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SUPPLEMENTARY MATERIAL
Supplementary Table 1.
Aging Stage
Adolescent
Puberty
Young Adult
Middle-Aged Adult
Elderly
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Rat Age
0-6 weeks
5-8 weeks
8 weeks – 11 months
11-15 months
Past 15 months

2169

Human Age
0-12 years
12-18 years
18-40 years
50-60 years
Past 60 years
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